Nektar Therapeutics (NASDAQ: NKTR): To Buy Or Not To Buy, That Is The Question

Nektar Therapeutics (NKTR) concluded trading on Wednesday at a closing price of $1.04, with 3.56 million shares of worth about $3.7 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 82.49% during that period and on April 3, 2024 the price saw a gain of about 9.47%. Currently the company’s common shares owned by public are about 191.38M shares, out of which, 178.15M shares are available for trading.

However, the stock later moved at a day high price of 0.9290, or with a gain of 9.47%. Stock saw a price change of 15.56% in past 5 days and over the past one month there was a price change of 15.56%. Year-to-date (YTD), NKTR shares are showing a performance of 84.07% which increased to 47.96% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.41 but also hit the highest price of $1.12 during that period. The average intraday trading volume for Nektar Therapeutics shares is 1.65 million. The stock is currently trading 16.58% above its 20-day simple moving average (SMA20), while that difference is up 39.40% for SMA50 and it goes to 69.24% higher than SMA200.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Nektar Therapeutics (NASDAQ: NKTR) currently have 191.38M outstanding shares and institutions hold larger chunk of about 65.28% of that.

The stock has a current market capitalization of $190.96M and its 3Y-monthly beta is at 0.90. It has posted earnings per share of -$1.46 in the same period. It has Quick Ratio of 6.14 while making debt-to-equity ratio of 1.76. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for NKTR, volatility over the week remained 11.37% while standing at 8.52% over the month.

Stock’s fiscal year EPS is expected to rise by 38.97% while it is estimated to increase by 19.49% in next year.

On May 10, 2023, Jefferies Upgrade their recommendations, while on February 24, 2023, Jefferies Downgrade their ratings for the stock with a price target of $1.50. Stock get an Underweight rating from JP Morgan on August 08, 2022.

Most Popular

Related Posts